Literature DB >> 20482721

Cervical cytology/histology discrepancy: a 4-year review of patient outcome.

E L Moss1, A Moran, G Douce, J Parkes, R W Todd, C W E Redman.   

Abstract

OBJECTIVE: To investigate the diagnosis, review and management of women identified as having a cytology/histology discrepancy.
METHODS: A review of all patients diagnosed with a discrepancy between referral smear and cervical histology was performed between January 2003 and December 2004. Cases were followed for a minimum of 4 years and patient management and outcome reviewed.
RESULTS: A significant discrepancy was identified in 79 cases, 0.1% of all smears (n = 80,926) analysed during the study period. A discrepancy between cytology and histology, obtained from large loop excision of the transformation zone (LLETZ), was confirmed by multidisciplinary review in 42 cases (53.2%). In 37 cases (46.8%) the cytological and/or histological diagnosis was revised; the cytology was significantly more likely than the histology to be amended (chi square P = 0.005), most often because cytology had been overcalled. Of the confirmed discrepancy cases, 33 (78.6%) were due to high-grade squamous cell or glandular abnormalities on cytology with a negative, inflammatory or human papillomavirus (HPV) infection on histology (HGC/NH). HGC/NH cases were managed by cytological follow-up in 29 (87.9%), of which 72.4% of the smears were negative when performed at least 6 months post-excision. During the 4-year follow-up period six women with a confirmed HGC/NH underwent a repeat cervical excision (hysterectomy or LLETZ), and of these, HPV effect was seen in two cases but no cervical intraepithelial neoplasia was detected in any of the histological specimens.
CONCLUSION: Cytology overcall was responsible for the majority of cytology/histology discrepancies. A confirmed discrepancy is not an indication for a further excisional biopsy but follow-up is essential because a small percentage of patients may have disease that has been missed.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20482721     DOI: 10.1111/j.1365-2303.2010.00754.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

Review 1.  Clinical application of DNA ploidy to cervical cancer screening: A review.

Authors:  David Garner
Journal:  World J Clin Oncol       Date:  2014-12-10

2.  Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer.

Authors:  Van T Nghiem; Kalatu R Davies; J Robert Beck; Michele Follen; Scott B Cantor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-29       Impact factor: 4.254

3.  Cervical Cytology-Histology Correlation Based on the American Society of Cytopathology Guideline (2017) at the Russian National Medical Research Center for Obstetrics, Gynecology, and Perinatology.

Authors:  Aleksandra Asaturova; Darya Dobrovolskaya; Alina Magnaeva; Anna Tregubova; Guldana Bayramova; Gennady Sukhikh
Journal:  Diagnostics (Basel)       Date:  2022-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.